CFG
70
6
KLAC
47
4
KMI
67
-2
CMA
61
5
AN
58
4
VFC
53
5
GS
75
2
HPQ
63
6
DE
63
3
TDC
80
4
ADSK
70
2
PPL
54
-5
GOOGL
40
-5
FDX
43
3
TROW
56
5
NKE
36
6
CPB
30
6
MCHP
41
4
LRCX
43
-2
NAVI
52
5
CFG
70
6
KLAC
47
4
KMI
67
-2
CMA
61
5
AN
58
4
VFC
53
5
GS
75
2
HPQ
63
6
DE
63
3
TDC
80
4
ADSK
70
2
PPL
54
-5
GOOGL
40
-5
FDX
43
3
TROW
56
5
NKE
36
6
CPB
30
6
MCHP
41
4
LRCX
43
-2
NAVI
52
5
Financhill
Back

Sage Therapeutics Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
27

SAGE
Sage Therapeutics

Last Price:
5.15
Seasonality Move:
13.05%

7 Day Trial

ALL ACCESS PASS

$ 7

Trade on Tuesday. Profit on Friday. Rinse & Repeat

Get the full details now.

Sage Therapeutics Price Quote

$5.15
-0.02 (6.19%)
(Updated: November 23, 2024 at 5:52 AM ET)

Sage Therapeutics Key Stats

Sell
27
Sage Therapeutics (SAGE) is a Sell
Day range:
$4.85 - $5.21
52-week range:
$4.62 - $28.26
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
2.94
P/B ratio:
0.57%
Volume:
870.9K
Avg. volume:
829.1K
1-year change:
-73.39%
Market cap:
$316.3M
Revenue:
$86.5M
EPS:
$-5.57

How Much Does Sage Therapeutics Make?

Is Sage Therapeutics Growing As A Company?

  • What Is Sage Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 3.37%
  • What Is Sage Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Sage Therapeutics Stock Price Performance

  • Did Sage Therapeutics Stock Go Up Last Month?
    Sage Therapeutics share price went down by -32.42% last month
  • Did SAGE's Share Price Rise Over The Last Year?
    SAGE share price fell by -73.39% over the past 1 year

What Is Sage Therapeutics 52-Week High & Low?

Sage Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Sage Therapeutics?

  • How Much Debt Does Sage Therapeutics Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Sage Therapeutics Have?
    Cash and short term investments quarterly total is $569.2M
  • What Is Sage Therapeutics’s Book Value Per Share?
    Book value per share is 9.02

Is Sage Therapeutics Cash Flow Positive?

  • What Is SAGE Cash Flow From Operations?
    Cash flow from operations (TTM) is -$320.2M
  • What Is Sage Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $10.4M
  • What Is Sage Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $262.2M

Sage Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    SAGE return on invested capital is -48.2%
  • What Is Sage Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -43.07%
  • What Is SAGE Return On Equity?
    ROE is a measure of profitability and is -48.2%

Sage Therapeutics Earnings Date & Stock Price

Sage Therapeutics Competitors

  • Who Are Sage Therapeutics's Competitors?
    Below is a list of companies who compete with Sage Therapeutics or are related in some way:
    • Biogen Inc (BIIB)
    • Johnson & Johnson (JNJ)
    • Lifecore Biomedical Inc (LFCR)
    • Organon & Co (OGN)
    • Outset Medical Inc (OM)

Sage Therapeutics Dividend Yield

Sage Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 1.32%
Revenue: 337.08% 9.37%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 17
Sell Recommendations: 0
Price Target: 9.47
Upside from Last Price: 83.18%

Major Shareholders

  • How many SAGE shares are owned by institutional investors?
    104.1M SAGE shares are owned by institutional investors
  • How many SAGE shares are owned by insiders?
    1.2M SAGE shares are owned by insiders